Recombinant Human SDHAF1 Protein，His

SDHAF1, or Sucinate Dehydrogenase Assembly Factor 1, has garnered significant attention in recent years due to its crucial role in the assembly and activity of succinate dehydrogenase (SDH), an essential enzyme in the mitochondrial respiratory chain and the tricarboxylic acid (TCA) cycle. Mutations or deficiencies in SDH components, including SDHAF1, have been linked to various pathologies, particularly hereditary paragangliomas and pheochromocytomas, which are neuroendocrine tumors associated with the dysregulation of hypoxia-inducible factors and cellular metabolism. Understanding the molecular mechanisms of SDHAF1 is vital for elucidating the biochemical pathways involved in these diseases and their broader implications for mitochondrial function. Recent studies have shown that SDHAF1 facilitates the maturation of SDH by promoting the incorporation of iron-sulfur clusters, crucial for its enzymatic activity. This highlights the importance of SDHAF1 not only in basic mitochondrial biology but also as a potential therapeutic target or biomarker in cancer and metabolic disorders. Exploring the structural and functional properties of SDHAF1 through recombination techniques is essential for advancing our knowledge of its role in SDH assembly and to develop strategies aimed at correcting the dysfunctions arising from its loss. As research progresses, the focus on recombinant SDHAF1 proteins may provide new insights into targeted treatments and interventions in related diseases, underscoring the protein's significance in both health and disease contexts.